Binal Maharaja
Psychiatry · Chicago, ILNPI 1508110990
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 392 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 392 payments — averaging $20.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$670
- Johnson & Johnson$641
- Bausch Health US, LLC$405
- plus $2K from 23 others
What the payments were for
- Food & beverage$7,927100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 85 | $1,359 |
| AbbVie(2 entities) | 72 | $1,333 |
| Otsuka America Pharmaceutical, Inc. | 45 | $1,135 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 27 | $670 |
| Johnson & Johnson | 27 | $641 |
| Bausch Health US, LLC | 20 | $405 |
| Lundbeck LLC | 23 | $377 |
| Vanda Pharmaceuticals Inc. | 11 | $295 |
| Neos Therapeutics, LP | 13 | $266 |
| Teva Pharmaceuticals USA, Inc. | 6 | $261 |
| E.r. Squibb & Sons, L.L.C. | 11 | $184 |
| Sunovion Pharmaceuticals Inc. | 10 | $134 |
| Supernus Pharmaceuticals, Inc. | 4 | $107 |
| Axsome Therapeutics, Inc. | 4 | $85 |
| Eisai Inc. | 5 | $75 |
| Shire North American Group Inc | 4 | $63 |
| Neuronetics, Inc. | 2 | $51 |
| Adlon Therapeutics L.p. | 3 | $51 |
| Neurocrine Biosciences, Inc. | 2 | $51 |
| Corium, LLC | 2 | $51 |
| Tris Pharma Inc | 2 | $48 |
| Biogen | 2 | $47 |
| Ironshore Pharmaceuticals Inc. | 2 | $45 |
| Avanir Pharmaceuticals, Inc. | 3 | $45 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Alfasigma USA, Inc. | 2 | $34 |
| TMS Neurohealth Centers Inc. | 1 | $33 |
| Alkermes, Inc. | 1 | $28 |
| Almatica Pharma LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,927 in reported general payments places this provider in the 90th percentile of 1,344 psychiatry providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 18 | $642 |
| Lamotrigine | 12 | $200 |
| Clonazepam | 11 | $153 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Chicago
- Mitchell GlaserChicago$752K
- Peter WeidenChicago$440K
- Michelle DeesChicago$289K
- Jeffrey RadoChicago$208K
- K Ranga KrishnanChicago$92K
- Richard BaerChicago$44K
- Adam GoldenbergChicago$23K
- Olusola AjiloreChicago$21K
- Emil CoccaroChicago$20K
- Guarava AgarwalChicago$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.